Evidence map›Paper›PMID 34012360›Full record

ArticleTheScientificWorldJournal2021

Forecasting the Effects of the New SARS-CoV-2 Variant in Europe.

Iván Area, Juan J Nieto

Abstract read
In one paragraph

Article in TheScientificWorldJournal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. One Year of the COVID-19 Pandemic in Galicia: A Global View of Age-Group Statistics during Three Waves.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Iván AreaUniversidade de Vigo, Departamento de Matemática Aplicada II, E.E. Aeronáutica e do Espazo, Campus As Lagoas-Ourense, Ourense 32004, Spain.ORCID https://orcid.org/0000-0003-0872-5017
Juan J NietoInstituto de Matemáticas, Universidade de Santiago de Compostela, Santiago de Compostela 15782, Spain.ORCID https://orcid.org/0000-0001-8202-6578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the emergence of a new SARS-CoV-2 variant, we use a previous model to simulate the behaviour of this new SARS-CoV-2 variant. The analysis and simulations are performed for Europe, in order to provide a global analysis of the pandemic. In this context, numerical results are obtained in the first 100 days of the pandemic assuming an infectivity of 70%, 56%, and 35%, respectively, higher for the new SAR-CoV-2 variant, as compared with the real data.

Indexed as

MutationCOVID-19Disease OutbreaksEuropeForecastingHumansPandemicsSARS-CoV-2

Identifiers

PMID34012360
PMCPMC8106412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.